These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3576880)

  • 1. Is there a role for induction therapy for locally advanced bladder cancer?
    Soloway MS
    Urology; 1987 Jun; 29(6):577-83. PubMed ID: 3576880
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemcitabine and cisplatin for advanced, metastatic bladder cancer.
    Cohen MH; Rothmann M
    J Clin Oncol; 2001 Feb; 19(4):1229-31. PubMed ID: 11181690
    [No Abstract]   [Full Text] [Related]  

  • 3. Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma.
    Small EJ
    J Clin Oncol; 2023 Aug; 41(23):3879-3880. PubMed ID: 37549481
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic therapy of bladder cancer.
    Salem PA
    Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of M-VAC in the adjuvant treatment of sarcomatoid carcinoma of the bladder].
    García González J; Pérez Fentes D; Aliste Santos C; Suárez Peñaranda JM; León Mateos L; López López R
    Actas Urol Esp; 2009 Apr; 33(4):447-9. PubMed ID: 19579900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adjuvant chemotherapy for locally advanced bladder cancer.
    Lehmann J; Retz M; Stöckle M
    World J Urol; 2001 Apr; 19(2):133-40. PubMed ID: 11374316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is neoadjuvant chemotherapy valid in invasive cancer of the bladder?].
    Matveev BP; Figurin KM
    Urol Nefrol (Mosk); 1998; (6):42-5. PubMed ID: 10051828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for advanced urothelial cancer.
    Yagoda A
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder.
    Sternberg CN; Arena MG; Calabresi F; De Carli P; Platania A; Zeuli M; Giannarelli D; Cancrini A; Pansadoro V
    Cancer; 1993 Sep; 72(6):1975-82. PubMed ID: 8364877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of apoptotic antitumor effect between angiogenesis inhibitor AGM-1470 and MVAC chemotherapy on rat urinary bladder cancer.
    Sejima T; Isoyama T; Miyagawa I
    Urol Int; 2004; 73(3):226-33. PubMed ID: 15539841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer.
    Necchi A; Mariani L; Giannatempo P; Raggi D; Farè E; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Maffezzini M; Pizzocaro G; De Braud FG; Gianni AM; Salvioni R
    Clin Genitourin Cancer; 2014 Jun; 12(3):203-209.e1. PubMed ID: 24394493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M-VAC chemotherapy in the management of locally advanced bladder cancer.
    Skinner DG
    J Urol; 1988 Mar; 139(3):570. PubMed ID: 3343745
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neoadjuvant chemotherapy in advanced-stage bladder carcinoma. A randomized prospective study comparing MVAC and MVEEC].
    Monica B; Larosa M; Frattini A; Macaluso G; Cocconi G; Passalacqua R; Leonardi F
    Arch Ital Urol Androl; 1994 Dec; 66(5):235-43. PubMed ID: 7812302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder?
    Zincke H; Sen SE; Hahn RG; Keating JP
    Mayo Clin Proc; 1988 Jan; 63(1):16-22. PubMed ID: 3336237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Orthotopic urinary diversions: the Paduan ileal neobladder. Experience at the Urologic Division of Magenta].
    De Giovanni M; Zanollo A
    Arch Ital Urol Androl; 1996 Dec; 68(5):299-301. PubMed ID: 9026230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: a 5-year followup.
    Srougi M; Simon SD
    J Urol; 1994 Mar; 151(3):593-7. PubMed ID: 8308965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?
    Gakis G; Stenzl A
    BJU Int; 2015 Jul; 116(1):3-4. PubMed ID: 26123071
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder.
    Miller RJ; Bahnson RR; Banner B; Ernstoff MS; O'Donnell WF
    Cancer; 1990 Jan; 65(2):207-10. PubMed ID: 2295043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.